OBESE
Clinical trials for OBESE explained in plain language.
Never miss a new study
Get alerted when new OBESE trials appear
Sign up with your email to follow new studies for OBESE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New supplement MB-1 aims to shed pounds in overweight adults
Disease control Not yet recruitingThis study tests whether a dietary supplement called MB-1 can help overweight and obese adults lose weight and improve metabolic health. One hundred participants will take either MB-1 or a placebo daily for 84 days. Researchers will measure changes in body weight, BMI, and other …
Matched conditions: OBESE
Phase: NA • Sponsor: Arrae • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New obesity drug SA030 enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests a single dose of SA030 injection in 40 overweight or obese adults aged 18–55. The main goal is to check safety and how the body handles the drug. It is the first time SA030 is given to humans, so results will guide future research.
Matched conditions: OBESE
Phase: PHASE1 • Sponsor: Suzhou Siran Biotechnology Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New Weight-Loss drug tested in kidney patients
Knowledge-focused Not yet recruitingThis early study will test a single dose of the experimental drug HDM1005 in 30 overweight or obese adults, some with moderate or severe kidney disease and some with healthy kidneys. The goal is to see how kidney function affects the drug's levels in the body and to check for saf…
Matched conditions: OBESE
Phase: PHASE1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC